<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Medicine</journal-id><journal-title-group><journal-title xml:lang="en">Russian Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский медицинский журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-2106</issn><issn publication-format="electronic">2412-9100</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">44153</article-id><article-id pub-id-type="doi">10.18821/0869-2106-2019-25-4-210-214</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">IS THERE A CONNECTION BETWEEN PYLORIC HELICOBACTER INFECTION AND METABOLIC DISORDERS?</article-title><trans-title-group xml:lang="ru"><trans-title>СУЩЕСТВУЕТ ЛИ СВЯЗЬ ПИЛОРИЧЕСКОЙ ХЕЛИКОБАКТЕРНОЙ ИНФЕКЦИИ С МЕТАБОЛИЧЕСКИМИ НАРУШЕНИЯМИ?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>German</surname><given-names>Serafima V.</given-names></name><name xml:lang="ru"><surname>Герман</surname><given-names>Серафима Вениаминовна</given-names></name></name-alternatives><bio xml:lang="en"><p>doctor of medical sciences, Leading research scientist, Laboratory of ecological physiology, biological climatology and Arctic medicine, Center of Strategic Planning and Management of Medical and Biological Health Risks, 129110, Moscow, Russian Federation</p></bio><bio xml:lang="ru"><p>доктор мед. наук, ведущий научный сотрудник лаборатории экологической физиологии, биоклиматологии и арктической медицины «Центр стратегического планирования и управления медико-биологическими рисками здоровью», 119992, Москва</p></bio><email>svgerman@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Modestova</surname><given-names>A. V</given-names></name><name xml:lang="ru"><surname>Модестова</surname><given-names>А. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zykova</surname><given-names>I. E</given-names></name><name xml:lang="ru"><surname>Зыкова</surname><given-names>И. Е</given-names></name></name-alternatives><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nikitin</surname><given-names>I. G</given-names></name><name xml:lang="ru"><surname>Никитин</surname><given-names>И. Г</given-names></name></name-alternatives><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Center of Strategic Planning and Management of Medical and Biological Health Risks</institution></aff><aff><institution xml:lang="ru">ФБГУ «Центр стратегического планирования и управления медико-биологическими рисками здоровью» Министерства здравоохранения Российской Федерации</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">N.I. Pirogov Russian National Research Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Министерства здравоохранения Российской Федерации</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Center of medico-biological and ecological problems of RAEN</institution></aff><aff><institution xml:lang="ru">Центр медико-биологических и экологических проблем РАЕН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2019-07-15" publication-format="electronic"><day>15</day><month>07</month><year>2019</year></pub-date><volume>25</volume><issue>4</issue><issue-title xml:lang="en">VOL 25, NO4 (2019)</issue-title><issue-title xml:lang="ru">ТОМ 25, №4 (2019)</issue-title><fpage>210</fpage><lpage>214</lpage><history><date date-type="received" iso-8601-date="2020-09-14"><day>14</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2019, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2019, ООО "Эко-Вектор"</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">ООО "Эко-Вектор"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://medjrf.com/0869-2106/article/view/44153">https://medjrf.com/0869-2106/article/view/44153</self-uri><abstract xml:lang="en"><p>Relevance. There are numerous publications of foreign authors about relationship between Pyloric Helicobacter (H. p.) infection with several gastroduodenal diseases, including metabolic disorders. Russia is one of the countries with high prevalence of H. p. infection and metabolic disorders. Determining their relationship is important for both prevention and treatment of metabolic disorders. Purpose - study the possibility of relationship between H. p. infection and type 2 diabetes, dyslipidemia, overweight and obesity. Methods and materials. The study included 1487 working residents of Moscow and the Moscow region, 931 men and 556 women, aged 21 to 77 years (median - 46). H. p. infection was diagnosed by detecting antibodies to IgG bacteria in the blood serum. In 698 infected individuals, the presence of a CagA strain, a marker of virulence of the bacterium, was studied using ELISA. Serum levels of basal glucose, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides were studied, and the body mass index was determined. Results. Infection was discovered in 1348 people (90.6%), CagA positive - 392 (56.2%). Type 2 diabetes was diagnosed in 77 people, 74 - H. p. positive (5.5% ), and 3 - H. p. negative (2.1%). CagA was studied for 31 persons with diabetes. CagA-positive bacterial strain was determined in 22 cases out of 31 (70.1%, p &lt;0,05 by criterion χ²). Dyslipidemia was detected in 175 persons (11.8%), 165 persons H. p. positive (12.2%), 10 - H. p. negative (7.2%) (p&gt;0,05, by criterion χ²). Among H. p. positive, overweight was registered in 884 cases (65.6%), in H. p. negative - in 74 cases (53.2%) (p&lt;0,05 by criterion χ²). Conclusion. In the presence of H. p. infection, the prevalence of metabolic abnormalities increases, which indicates a possible connection between them.</p></abstract><trans-abstract xml:lang="ru"><p>Актуальность. Имеются многочисленные зарубежные сообщения об ассоциации пилорической хеликобактерной инфекции (H. р.) с различной внежелудочной патологией, включая метаболические нарушения. Россия относится к странам с высокой распространенностью H. р. инфекции и метаболических заболеваний. Решение вопроса об их связи важно для профилактики и лечения метаболических нарушений. Цель - изучить возможность существования связи инфекции H. р. с сахарным диабетом 2 типа, дислипидемией, ожирением и избыточной массой тела. Материал и методы. Обследовано 1487 работающих жителей Москвы и Подмосковья, 931 мужчина и 556 женщин, в возрасте от 21 до 77 лет (медиана 46). Инфекцию H. р. выявляли путем определения в сыворотке крови антител к бактерии класса IgG методом ИФА. У 698 инфицированных изучали наличие CagA штамма с помощью ИФА. Исследовали сывороточные уровни базальной глюкозы, общего холестерина, холестерина липопротеинов низкой плотности, холестерина липопротеинов высокой плотности, триглицеридов, определяли индекс массы тела. Результаты. Инфицировано было 1348 человек (90,6 %), CagA положительных - 392 (56,2%). Сахарный диабет 2 типа диагностирован у 77 человек, 74 - H. p. положительных (5,5%) и у 3 - H. p. негативных (2,1%). При сахарном диабете CagA положительный штамм бактерии определен в 22 случаях из 31 (70,1%, p&lt;0,05, по критерию χ²). Дислипидемия обнаружена у 175 человек (11,8%), 165 человек H. p. положительных (12,2%), 10 - H. p. отрицательных (7,2%) (p&gt;0,05, по критерию χ²). Среди H. p. позитивных избыточная масса тела зарегистрирована в 884 случаях (65,6%), у H. p. негативных - в 74 случаях (53,2%) (p&gt;0,05, по критерию χ²). Заключение. При наличии инфекции H. p. распространенность метаболических нарушений увеличивается, что свидетельствует в пользу связи между ними.</p></trans-abstract><kwd-group xml:lang="en"><kwd>CagA</kwd><kwd>H. p. infection</kwd><kwd>CagA</kwd><kwd>diabetes mellitus</kwd><kwd>dyslipidemia</kwd><kwd>overweight</kwd><kwd>obesity</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>инфекция H. p.</kwd><kwd>сахарный диабет</kwd><kwd>дислипидемия</kwd><kwd>избыточная масса тела</kwd><kwd>ожирение</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Решетников О.В., Курилович С.А., Кротов С.А., Кротова В.А. Мониторинг инфекции, вызываемой Helicobacter pylori в Новосибирске. Журнал микробиологии, эпидемиологии, иммунобиологии. 2008; 1: 99-100.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Герман С.В., Зыкова И.Е., Ермаков Н.В., Модестова А.В. Распространенность инфекции Н. pylori среди населения Москвы. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2010; 2: 25-30.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Дедов И.И., Шестакова М.В., Викулова О.К. Эпидемиология сахарного диабета в Российской Федерации: клинико-статистический анализ по данным Федерального регистра сахарного диабета. Сахарный диабет. 2017; 20(1): 13-41. Doi: 10.14341/DM201535-22</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Vaarala O., Yki-Jarvinen H. Diabetes: Should we treat infection or inflammation to prevent T2D? Nat Rev Endocrinol. 2012; 8: 323-5.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Simon L., Tornoczky J., Toth M., Jambor M., Sudar Z. The significance of Campylobacter pylori infection in gastroenterologic and diabetic practice. Orv Hetil. 1989; 130: 1325-9.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Jeon C.Y., Haan M.N., Cheng.C., Clayton E.R., Mayeda E.R., Miller J.W., Aiello A.E. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care. 2012; 5(3): 520-5. Doi: 10.2337/dc11-1043</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Zhou X., Zhang C., Wu J., Zhang G. Association between Helicobacter pylori infection and diabetes mellitus : a meta-analysis of observational studies. Diabetes Res Clin Pract. 2013; 99: 200-8. Doi: 10.1016/j.diabres.2012.11.012</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Yang G.H., Wu J.S., Yang Y.C,. Huang Y.H., Lu F.H., Chang C.J. Gastric Helicobacter pylori infection associated with risk of diabetes mellitus, but not prediabetes. J Gastroenterol Hepatol. 2014; 29: 1794-9. Doi: 10.1111/jgh.12617</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Bajaj S., Rekwal L., Misra S.P., Misra V., Yadav R.K., Srivastava A. Association of Helicobacter pylori infection with type 2 diabetes. Indian J Endocrinol Metab. 2014; 18: 694-9.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Franceshi F., Gasbarrini A., Polyzos S.A., Kountouras J. Extragastric diseases and Helicobacter pylori. Helicobacter. 2015; 20(S1): 40-6. Doi: 10.1111/hel.12256</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Tsay F-W., Hsu P-I. H. pylori infection and extra-gastroduodenal diseases. J Biomed Sci. 2018; 25: 65.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Ibrahim A., Zaher T., Ghonemy T.A., El-Azim S.A., El-Azim M.A., Ramadan A. Impact of cytotoxin-associated gene A of Helicobacter pylori strains on microalbuminuria in type 2 diabetes. Saud J Kidney Dis Transpl. 2010; 21(4): 694-700. Doi: 10.4314/ajnt.v3i2.58892</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Buzas G.M. Metabolic consequences of Helicobacter pylori infection and eradication. World J Gastroenterol. 2014; 20(18): 5226-34. Doi: 10.3748wjg.v20.i18.5226</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Marietti M., Gasbarrini A., Saracco G., PellicanoR. Helicobacter pylori infection and diabetes mellitus: the 2013 state of art. Panminerva Med. 2013; 55(3): 277-81.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Oluyemi A., Anomneze E., Smith S., Fasanmade O. Prevalence of a marker of active Helicobacter pylori infection among patients with type 2 diabetes mellitus in Lagos, Nigeria. BMC Res Notes. 2012; 5: 84. Doi: 10.1186/1756-0500-5-284</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Sotuneh N., Hosseini S.R., Shokri-Shiravi J., Bijani A., Ghadimi R. Helicobacter pylori infection and metabolic parametrs: is there association in elderly population? Int J Prev. 2014; 5(12): 1537-52.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Niemelä S., Kartiunen T., Korhonen H., Läärä H., Kartiunen R., Ikäheimo M., Kesäniemi Y.A. Could Helicobacter pylori infection increase the risk of coronary artery disease by modifying serum lipid concentration? Heart. 1996; 75: 573-5.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Sharnagl H., Kist M., Grawitz A.B., Koenig W., Wieland H., Marz W. Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol. Am J Cardiol. 2004; 93: 219-20.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Satoh H., Saiyo Y., Yoshioka E., Tsutsui H. Helicobacter pylori infection is a significant risk for modified lipid profile in Japanese male subjects. J Atheroscler Thromb. 2010; 17: 1041-8.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Kim H.-L., Jeon H.H., Park I.Y., Choi J.M., Kang J.S., Min K.-W. Helicobacter pylori infection is associated with elevated low density lipoprotein cholesterol levels in elderly Koreans. J Korea Med Sci. 2011; 26(5): 654-8. Doi: 10.3346/jkms.2011.26.5.654</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Nam S.Y., Ryu K.H., Park B.J., Park S. Effects of Helicobacter pylori infection and its eradication on lipid profiles and cardiovascular diseases. Helicobacter. 2014; 20(2): 125-32. Doi: 10.1111/hel.12182</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Gravina A.G., Zagari R.M., De Musis C., Romano L., Loguerzio C., Romano M. Helicobacter pylori and extragastric diseases: A review. World J Gastroenterol. 2018; 24(29): 3204-21.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Chen T.P., Hung H.F., Chen M.K., Lai H.H., Hsu W.F., Huang K.C., Yang K.C. Helicobacter pylori infection is positively associated with metabolic syndrome in Taiwanese adults: A crosssectional study. Helicobacter. 2015; 20: 184-91.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Sotuneh N., Hosseini S.R., Shokri- Shirvani J., Bijani A., Ghadimi R. Helicobacter pylori infection and metabolic parameters: is there an association in elderly population? Int J Prev Med. 2014; 5(12): 1537-42.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Cho I., Blaser M.J., Francois F., Mathew J.P., Ye X.Y., Goldberg J.D. Helicobacter pylori and overweight status in the United States. Data from the third national health and nutrition examination survey. Am J Epidemiol. 2005; 162: 579-84.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Wu M.S., Lee W.J., Wang H.H., Huang S.P., Lin J.T. A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan. Arch Intern Med. 2005; 165: 1552-5.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Lender N., Talley N.J., Enck P., Haag S., Zipfel S., Morrison M., Holtmann G.J. Review article:associations between Helicobacter pylori and obesity - an ecological study. Alimentary Pharmacology and Therapeutics. 2014; (40)1: 24-31.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Arslan E., Atilgan H., Yavasoglu I. The prevalence of Helicobacter pylori in obese subjects. Eur J Intern Med. 2009; 20: 695-7.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Yang G.H., Wu J.S., YangY,C,. Huang Y.H., Lu F.H., Chang C.J. Obesity associated with increased risk of gastric Helicobacter pylori infection in an elderly Chinese population. J Am Geriatrics Society. 2014; 62: 190-2.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Zhang V., Du T., Chen Xi, Yu X., Tu L., Zhang C. Association between Helicobacter pylori infection and overweight or obesity in a Chinese population. J Infect Dev Ctries. 2015; 9(9): 945-53.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Chen L.W., Kuo S.F., Chen C.H., Chien C H., Lin C.L., Chien R.N. A community-based study on the association between Helicobacter pylori infection and obesity. Sci Rep. 2018; 8(11): 10746. Doi:10.1038/41598-018-28792.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Kopacova M., Bures J., Koupil I., Rejchrt S., Vorisek V., Seifert B. Pozler O., Zivny P., Douda T., Palicka V., Holcik J. Body indices and basic vital sings in Helicobacter pylori positive and negative persons. Eur J Epidemiol. 2007; 22(1): 67-75. Doi: 10.1007/s10654-006-9090-1</mixed-citation></ref></ref-list></back></article>
